目的:探讨腰痛珍方治疗腰椎间盘突出症的临床疗效。方法:选取2020年1月-2024年11月收治的100例腰椎间盘突出症患者,采用抽签法完成受试者分组设计。对照组采用常规保守疗法,治疗组则在保守治疗基础上联合应用腰痛珍方,通过视觉模拟量表(VAS)、日本骨科协会评分(JOA)及Oswestry功能障碍指数(ODI)评估疗效,并监测不良反应。结果:治疗组总有效率(94.00%)显著高于对照组(68.00%)(P＜0.05)。治疗后两组VAS评分(治疗组3.20±0.80 vs.对照组5.60±1.20)和ODI指数(治疗组18.50±3.10 vs.对照组29.80±4.50)均显著降低,JOA评分(治疗组24.70±2.30 vs.对照组18.90±2.10)显著提升(P＜0.05)。相较于对照组,治疗组在各项指标上均呈现更显著的改善(P＜0.05),同时未观察到严重不良反应发生。结论:腰痛珍方能有效缓解腰椎间盘突出症患者的疼痛症状,改善功能活动,临床疗效确切。
Objective: To investigate the clinical efficacy of Yaotong prescription in the treatment of lumbar disc herniation. Methods: A total of 100 patients with lumbar disc herniation admitted from January 2020 to November 2024 were selected, and the grouping design of subjects was completed by drawing lots. The control group was treated with conventional conservative therapy, while the treatment group was treated with Yaotong prescription on the basis of conservative treatment. The efficacy was evaluated by Visual Analogue Scale (VAS), Japanese Orthopaedic Association score (JOA) and Oswestry Dysfunction Index (ODI), and adverse reactions were monitored. Results: The total effective rate of the treatment group (94.00%) was significantly higher than that of the control group (68.00%) (P＜0.05). After treatment, the VAS score (treatment group 3.20±0.80 vs. control group 5.60±1.20) and ODI index (treatment group 18.50±3.10 vs. control group 29.80±4.50) of the two groups were significantly decreased, and the JOA score (treatment group 24.70±2.30 vs. control group 18.90±2.10) was significantly increased (P＜0.05), while compared with the control group, the treatment group showed more significant improvement in all indicators (P＜0.05), and no serious adverse reactions were observed. Conclusion: Yaotong prescription can effectively relieve the pain symptoms of patients with lumbar disc herniation, improve their functional activities, and has a definite clinical effect.
[1] 杨洁, 马方方, 郝冰, 等.个性化护理对腰椎间盘突出症患者生活质量及心理状态的影响[J].中国医药导报, 2012, 9(6): 137-139.
[2] 王虹颖.牵引针刺拔罐结合中药熏蒸治疗颈椎间盘突出症的临床疗效[J].内蒙古中医药, 2025, 44(2): 110-112.
[3] 欧礼, 唐本夫.中医辨证治疗腰椎间盘突出症52例临床观察[J].中医药导报, 2013, 19(2): 47-48.
[4] 陈江平, 王亮, 吴宽, 等.腰突症Ⅰ号方治疗寒湿痹阻证腰椎间盘突出症的临床观察[J].中医药导报, 2019, 25(2): 89-92.
[5] 国家中医药管理局.中医病证诊断疗效标准[M].南京: 南京大学出版社.
[6] 谭黄圣, 王银波, 黄勇, 等.身痛逐瘀汤合地龙汤加减治疗腰椎间盘突出症气滞血瘀证的疗效及机制[J].中国实验方剂学杂志, 2025, 31(1): 47-54.
[7] Huskisson EC.Measurement of pain[J].Lancet, 1974, 2 (7889) :1127-1131.
[8] 徐宏光, 张敏, 王弘, 等.QLS-DSD与JOA评分量表在脊柱退行性疾病患者评分应用中的比较[J].中国骨与关节外科, 2013, 6(6): 482-486.
[9] 郑光新, 赵晓鸥, 刘广林, 等.Oswestry功能障碍指数评定腰痛患者的可信性[J].中国脊柱脊髓杂志, 2002, (1): 13-15.
[10] 郭进发, 陈海鹏.温针灸治疗腰椎间盘突出症患者的效果及对局部微循环的影响[J].中国医学创新, 2022, 19(15): 66-70.
[11] 方圣杰, 魏戌, 唐彬, 等.中药治疗神经根型颈椎病作用机制[J].中国现代中药, 2022, 24(5): 933-938.
[12] 张妤, 浦斌红, 邓佳南, 等.颈椎蒸敷方热敷治疗颈椎病临床研究[J].上海中医药杂志, 2016, 50(4): 53-54, 63.
[13] 赵明阳.加味桂枝茯苓丸对PDPN大鼠神经微循环的改善以及CD34、vWF表达的影响[D].沈阳: 辽宁中医药大学, 2023.
[14] 王雪, 姜旻, 刘琼, 等.合理使用扩张血管及改善微循环中药注射剂[J].西南国防医药, 2010, 20(3): 310-312.
[15] 李丹.超声引导下腹横筋膜平面阻滞联合桃红四物汤减轻带状疱疹后遗神经痛患者疼痛程度的效果观察[J].中国现代药物应用, 2025, 19(13): 145-148.
[16] 李雅玲, 冯威, 陈航宇, 等.齐墩果酸药理作用研究[J].生物技术世界, 2015, 12(4): 125, 127.
[17] 黄威.京尼平苷对巨噬细胞上清液刺激RSC-364细胞的影响及作用机制的研究[D].石家庄: 河北医科大学, 2015.
[18] 高风, 郭丽君, 王安铸, 等.脱氢紫堇碱的药理作用研究现状与展望[J].中华中医药杂志, 2023, 38(11): 5377-5380.
[19] 董佩, 袁普卫, 白元帅, 等.针刀疗法治疗强直性脊柱炎研究进展[J].河北中医, 2024, 46(11): 1918-1921.
[20] 李东飞, 刘建航, 邓宇, 等.青少年特发性脊柱侧弯治疗研究进展[J].广西中医药, 2022, 45(4): 69-73.
[21] 何小姣, 杨万琼, 曹均, 等.盘龙七片联合甲钴胺治疗寒湿痹阻型腰椎间盘突出症临床观察[J].中国药业, 2025, 34(13): 105-108.
[22] 冯亚娣, 张世民, 王国军, 等.七芍活血方治疗腰椎间盘突出症气滞血瘀证临床研究[J].中国中医药信息杂志, 2025, 32(7): 142-147.
[23] 岑康铭, 赖象权.中药熏洗联合吲哚美辛三七冰片栓治疗湿热下注型肛门坠胀临床观察[J].中国民族民间医药, 2021, 30(8): 94-97, 114.
